Proteon logo     Print Page | Close Window

SEC Filings

SC 13D/A
FLYNN JAMES E filed this Form SC 13D/A on 12/04/2017
Entire Document
 

 

Page 13 of 17

 

(4) Deerfield Partners

 

Number of shares: 197,424

Percentage of shares: 1.12%*

 

(5) Deerfield Special Situations Fund

 

Number of shares: 149,676

Percentage of shares: 0.85%*

 

(6) Deerfield International Master Fund

 

Number of Shares: 0

Percentage of Shares: 0.00%

 

(7) Deerfield Private Design Fund III

 

Number of Shares: 877,799

Percentage of Shares: 4.98%*

 

(8) Deerfield Private Design Fund IV

 

Number of Shares: 16,082,018

Percentage of Shares: 9.985%*

 

(9) Deerfield Mgmt IV

 

Number of Shares: 16,082,018

Percentage of Shares: 9.985%*

 

(10) Flynn

 

Number of shares: 17,306,917

Percentage of shares: 9.985%*

 

*Percentage beneficial ownership reported herein reflects 17,619,418 shares of Common Stock outstanding as of October 31, 2017, as reported in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2017.

 

(b)

 

(1) Deerfield Management

 

Sole power to vote or direct the vote: 0

Shared power to vote or direct the vote: 17,306,917

Sole power to dispose or to direct the disposition: 0

Shared power to dispose or direct the disposition: 17,306,917